You are here: Home » Current Affairs » Coronavirus » News
Business Standard

Seven important Coronavirus vaccine updates that you need to know

Listen to the podcast to know about the current status of the Covid-19 vaccine in India and other parts of the world

Coronavirus Vaccine | Coronavirus | Coronavirus Tests

Sukanya Roy  |  New Delhi 

As India gets ready for a massive Covid vaccination programme, heath experts on Sunday said that 21 days is an ideal gap between the first and the second booster dose, and those who get vaccinated will have to maintain, for a certain time period, the same health and hygiene regimen as they are supposed to do without the vaccine.

Hyderabad-based vaccine major Bharat Biotech, which had applied for an accelerated approval from the drug regulator based on phase-1 and 2 clinical trial data last week, said that it has already recruited 8,000 volunteers for a 22,000-subject, phase-3 clinical trial.

There is no pressure on the drug regulator to take a decision on the Covid-19 vaccine approval one way or another, and the final call on granting emergency-use authorisation will be made on sound scientific principles within a few days, member V K Paul said on Saturday. Addressing Ficci’s 93rd annual general meeting, Paul said, “It is an Apollo-11 moment for Indian science...The decision on vaccines will be taken by a panel which represents India’s scientific capital. We will wait till all parameters are met.”

Listen to the podcast for more

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Sun, December 13 2020. 16:36 IST